Compare Recursion Pharmaceuticals Inc (RXRX) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs United States Natural Gas Fund — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while United States Natural Gas Fund trades at $10.4. Which is the better fit depends on your goals.
| RXRX | UNG | |
|---|---|---|
Market Cap | $1.53B | — |
Sector | Health | Commodities - Energy |
52-Week High | $6.79 | $16.90 |
52-Week Low | $2.84 | $10.15 |
Enterprise Value | $946.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
